Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06476938 · ClinicalTrials.gov registry record · NA
Testing Gene PilotLX With Latinx Cancer Patients
A NA study of Cancer, sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 232
- Enrollment target
- 4
- Study locations
NCT06476938 is a NA study of Cancer that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 232 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT06476938, a NA study of Cancer, is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a randomized controlled trial designed to evaluate the efficacy of an electronic health decision support tool called Gene PilotLX to increase informed decision making regarding hereditary risk information from tumor genomic profiling (TGP) test among Latinx cancer patients recruited at four cancer centers.
Conditions Studied
Interventions
- OTHER Gene PilotLX
Study Locations (4)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
- Temple University Hospital - Philadelphia
New Jersey
- MD Anderson Cancer Center at Cooper - Camden
New York
- Herbert Irving Comprehensive Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2025-05-30 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06476938
The ClinicalTrials.gov registry entry for NCT06476938 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Gene PilotLX is the first listed.
NCT06476938 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT06476938 about?
NCT06476938 is a clinical study titled "Testing Gene PilotLX With Latinx Cancer Patients". This is a randomized controlled trial designed to evaluate the efficacy of an electronic health decision support tool called Gene PilotLX to increase informed decision making regarding hereditary risk information from tumor genomic profiling (TGP) test among Latinx cancer patients recruited at four ...
What is the current status of trial NCT06476938?
This trial is currently recruiting. It is a NA study. The enrollment target is 232 participants. The study started on 2025-05-30. Estimated completion is 2027-12-31.
What conditions does trial NCT06476938 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT06476938?
The interventions under investigation include: Gene PilotLX (OTHER).
Who is sponsoring clinical trial NCT06476938?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06476938 being conducted?
This trial has 4 study locations across New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.